TGX-221
TGX-221 is a potent, selective, cell membrane-permeable inhibitor of the PI3K p110β catalytic subunit. TGX221 also showed significant selectivity in inhibiting cell motility and tumorigenesis in ccRCC cells harboring VHL and SETD2 mutations. TGX221 is a novel inhibitor with high selectivity for ccRCC harboring VHL and SETD2 mutations.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0206 |
| Pricing | 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, inquire |